Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

1 février 2018

07:00
Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") , a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced a new clinical collaboration with AstraZeneca  to evaluate the safety...

07:00
Imago BioSciences, a clinical-stage pharmaceutical company developing novel therapies for hematological and inflammatory diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted their Investigational New Drug (IND)...

07:00
The Food and Drug Administration has issued official guidance, giving the green light to reimburse patients for travel expenses to clinical trial sites. It allows all cancer patients access to potentially life-saving treatments....

03:30
Results from the SUSTAIN 7 trial, which investigated the efficacy and safety of 0.5 mg semaglutide compared with 0.75 mg dulaglutide and 1.0 mg semaglutide compared with 1.5 mg dulaglutide, when added to metformin, have been published in The Lancet...


31 janvier 2018

23:00
ClinOne, a mobile clinical trial management solution, is revolutionizing how patients manage the complexities of a clinical trial, navigate appointments, and manage their research documents with the first proactive patient engagement monitoring...

17:09
Novartis today announced updated results from the pivotal ELIANA clinical trial of Kymriahtm (tisagenlecleucel), formerly CTL019, in relapsed or refractory (r/r) pediatric and young adult patients with B-cell acute lymphoblastic leukemia (ALL) have...

17:00
Updated results from a global clinical trial of the CAR T-cell therapy, tisagenlecleucel, a landmark personalized treatment for a high-risk form of acute lymphoblastic leukemia (ALL), reveal that children and young adults continued to show high rates...

14:55
A study in AACC's The Journal of Applied Laboratory Medicine has for the first time established female-specific reference ranges for several biological variables that play key roles in thrombosis?or blood clotting?during pregnancy. This research...

14:26
AZTherapies, Inc. is a privately held advanced clinical stage pharmaceutical company located in Boston, MA that is developing breakthrough treatments for Alzheimer's disease (AD), ischemic stroke, and other neurological diseases associated with...

12:00
A new study* by researchers at the Massachusetts Institute of Technology found that nearly 14% of all drugs in clinical trials eventually win approval from the FDA?an amount that is much higher than previous studies indicate. The researchers also...

09:04
SkylineDx today announced a strategic collaboration with Mayo Clinic to develop novel diagnostic tests which will improve clinical decision making for melanoma patients. For SkylineDx, the collaboration with the renowned Mayo Clinic is an important...

08:15
OrphoMed, Inc., a clinical-stage biopharmaceutical company developing first-in-class dimer therapeutics, announced today that Nikhilesh N. Singh, Ph.D., President and Chief Executive Officer, will present at the 20th Annual BIO CEO & Investor...

08:00
Medidata , the leading global provider of cloud-based technology and data analytics for clinical research, and Syapse, a market leader in precision medicine solutions, have announced a new partnership to transform oncology clinical trials for the age...

08:00
Intec Pharma Ltd. , a clinical stage biopharmaceutical company focused on developing pharmaceutical therapies based on its proprietary Accordion Pilltm platform technology, today announced it has named R. Michael Gendreau, M.D., Ph.D. to the...

07:00
Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to radiation therapy and improves survival in animal models of the disease. The study, published Jan 21st in the International Journal of Radiation...

05:00
Plymouth Hospitals NHS Trust, the largest hospital in the South West Peninsula region of England, has joined TriNetX's global health research network to help bring new therapies to its patients faster by gaining access to the earliest and most...

03:04
SkylineDx today announced a strategic collaboration with Mayo Clinic to develop novel diagnostic tests which will improve clinical decision making for melanoma patients. For SkylineDx, the collaboration with the renowned Mayo Clinic is an important...


30 janvier 2018

16:45
Mallinckrodt plc , a leading global specialty pharmaceutical company, today confirmed enrollment of the first patient in the company's Phase 4, multi-center, randomized, double-blind, placebo-controlled pilot study to further assess the efficacy of...

09:35
Cumberland Pharmaceuticals Inc. , a U.S. specialty pharmaceutical company and Clinigen Group plc (AIM: CLIN, 'Clinigen'), the global pharmaceutical and services company, announce a new publication in Leukemia & Lymphoma, with study results showing...

09:05
Leading Indian CRO enters partnership with ArisGlobal to enhance its delivery capability in operations and biometrics ArisGlobal, a leading provider of integrated cloud-based software solutions for life sciences, today announced its...

09:00
Amgen today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending a label variation for KYPROLIS® (carfilzomib) to include updated overall survival...

08:50
MedShape, Inc., the industry leader in orthopaedic devices using advanced functional materials, announced today that the first surgeries using the DynaNail® XL TTC Fusion System were successfully performed. The DynaNail XL represents the longer...

08:30
Co-sponsors of the 2018 Multidisciplinary Head and Neck Cancers Symposium announced today that four abstracts will be highlighted in the meeting's official press program. Researchers will present the findings of these studies in an online news...

08:05
Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, comments on the recently updated consensus clinical...

08:00
Aldeyra Therapeutics, Inc. (Aldeyra), a clinical-stage biotechnology company devoted to treating inflammation and inborn errors of metabolism, today announced that it has enrolled the first patient in a Phase 2b clinical trial of topical ocular...

08:00
Eisai Inc. and Boston University School of Medicine have formed a research collaboration to study the effects of Alzheimer's disease-associated genetic variants on the behavior of brain cells, called microglia. Recent discoveries regarding the...

07:30
BiomX Ltd., a microbiome company developing customized phage therapies, today announced that it has exclusively sub-licensed from JSR Corporation a set of bacterial targets for the development and commercialization of phage therapies that eradicate...

05:15
Scientists discovered how a gene mutation affects T cell function to promote immune disorders and then tested a treatment based on the discovery?successfully fixing donated immune cells from a 16-year-old boy with an abnormally low level of white...

03:30
DexCom, Inc. , announced today the publication of a novel head-to-head study that demonstrates that Dexcom G5 Mobile® Continuous Glucose Monitoring (CGM) System use reduces time spent in hypoglycaemia in people with type 1 diabetes with severe...

02:58
ENDOCUFF VISION®a augmenté globalement le taux de détection des adénomes de 36,2 % à 40,9 % (P=0,02)[i]   56 cancers colorectaux ont été détectés au total chez 36 patients en utilisant ENDOCUFF VISION® et chez 20 patients durant une coloscopie...

02:00
ENDOCUFF VISION®increased adenoma detection rate globally from 36.2% to 40.9% (P=0.02)[i] A total of 56 colorectal cancers were detected in 36 patients when using ENDOCUFF VISION® and in 20 patients during standard colonoscopy[i] Norgine B.V. and...


29 janvier 2018

10:10
New Jersey Bariatric Center is accepting new participants in a weight loss surgery study that makes bariatric surgery accessible to patients with a body mass index (BMI) of 30-35, lower than the current threshold to qualify for surgery. The study,...

10:00
Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") today announced new data to be presented at the 2018 Genitourinary Cancers Symposium of the American Society of Clinical Oncology (ASCO GU) taking place on February...

09:00
SillaJen, Inc., (KOSDAQ:215600), a clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, announced the initiation of a Phase 1/2 clinical trial of pexastimogene devacirepvec (Pexa-Vec) in...

08:25
DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies, today announced the first systematic review of prospective studies comparing postoperative outcomes through 90 days of Anterior Approach versus Posterior Approach in primary...

07:00
ITUS Corporation , today announced that it presented positive data from its early cancer detection technology on January 26th at the American Society of Clinical Oncology-Society for Immunotherapy of Cancer (ASCO-SITC) Clinical Immuno-oncology...

06:30
Confirmation de la conception de l'étude clinique lors d'une rencontre de type C avec la FDA tenue le 3 janvier 2018 Critères d'inclusion simplifiés des patients afin d'inclure les patients FPI traités ou non à l'aide de la norme des soins (le...

06:30
Prometic...

02:52
BerGenBio ASA (OSE:...

02:48
BerGenBio ASA (OSE:...

02:00
PROSPER est la première étude européenne et australienne financée par Norgine et fondée sur des données probantes menée sur l'expérience des patients atteints d'encéphalopathie hépatique prenant de la rifaximine alpha 550 mg  Norgine B.V. a...

02:00
PROSPER is the first Norgine funded European and Australian real world evidence study of patients' experience with hepatic encephalopathy taking rifaximin-? 550mg  Norgine B.V. today announced the publication of the study design of PROSPER (The...


27 janvier 2018

06:17
PTC Therapeutics, Inc. today announced the presentation of early interim data from Part 1, the dose-finding portion of the FIREFISH study. FIREFISH is a two-part seamless, open-label, multi-center study to investigate the safety and efficacy of...


26 janvier 2018

11:54
Hier, l'American Heart Association et l'American Stroke Association ont mis à jour les lignes directrices sur les accidents ischémiques cérébrovasculaires (AVC). La nouvelle recommandation a élargi la fenêtre thérapeutique, de six à 16 heures, sur la...

09:41
Hier, l'American Heart Association et l'American Stroke Association ont mis à jour lignes directrices sur les accidents ischémiques. La nouvelle recommandation prolonge la fenêtre de traitement de six à 16 heures sur la base de données cliniques...

09:00
Results from the Wingspan® StEnt System Post MArket SurVEillance Study (WEAVEtm Trial) were presented yesterday at the International Stroke Conference, providing compelling evidence that more patients suffering from intracranial atherosclerotic...

08:53
We are advised by ThyroSeq that journalists and other readers should disregard the news release, American Cancer Society® Published Performance Results Of ThyroSeq® V3, and the associated correction statement issued 25-Jan-2018 over PR Newswire. A...

05:00
Pharmaceutical and device manufacturers as well as many patient recruitment companies are becoming increasingly aware of the importance of employing medical professionals at call centers to improve clinical trial patient recruitment and retention....

02:45
Flow Neuroscience, une entreprise suédoise d'équipement médical, s'efforce de développer un nouveau traitement pour la dépression, combinant la stimulation cérébrale avec la thérapie comportementale. La société vient d'obtenir un investissement de...

02:45
Flow Neuroscience, a Sweden-based medtech company is developing a new treatment for depression combining brain stimulation with behavioral therapy. They have now secured a $1.1 million seed round from Khosla Ventures, SOSV and a Swedish angel...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15